An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials

Centerline

Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...

Read more

Adaptive Radiotherapy Post-COVID: An Interview with Professor Patricia Price

Centerline

As many facilities move back towards normal operations after COVID restrictions, Professor Pat Price, a leading expert on radiation oncology, discusses what that means for adaptive radiotherapy.

Read more

Royal Surrey NHS Foundation Trust, Guildford, UK: Focusing on Patients Who Will Benefit Most

Centerline

The Royal Surrey County Hospital comprises two sites about 20 miles apart in the county of Surrey, UK. Across the two sites, radiotherapy clinicians treat about 3,500 patients a year, typically with IMRT or RapidArc® radiotherapy, including stereotactic a...

Read more

Henry Ford Cancer Institute (HFCI), Michigan: Looking Towards Adaptation During Five-Fraction SBRT

Centerline

Henry Ford Allegiance (HFA) is a community-based hospital about 60 miles west of the main Henry Ford Health System campus. Its HFCI radiation oncology clinic treats approximately 450 patients a year, with more than 9,000 external beam treatments delivered...

Read more

Royal North Shore Hospital, Sydney, Australia: Adapting to Changes in the Target

Centerline

The Royal North Shore Hospital in Sydney, Australia, also deployed its Ethos™ therapy system about a year ago. Royal North Shore is a small, state-funded facility that treats about 1,500 cancer patients a year and its head of medical physics, Assistant P...

Read more

Icon Group, Australia: Choosing Adaptive Fractions 98 Percent of The Time

Centerline

Icon Group operates 30 cancer centers in Australia, one in New Zealand, six in Singapore, four in Mainland China, and two in Hong Kong, with several in development across their international network.

Read more

The Treatment Adapts so the Patient Doesn’t Have To: Ethos at Queen’s Hospital, Romford, UK

Centerline

Queens Hospital treats around 1,200 patients a year and was the first facility in the UK to deploy and start using an Ethos™ therapy system in August 2020, despite being in the midst of the COVID pandemic.

Read more

Ethos Adaptive Radiotherapy: Redefining Cancer Treatment

Centerline

The use of online adaptive radiotherapy has expanded around the world since Varian introduced Ethos™ therapy at ASTRO in 2019. Through groups such as the Adaptive Intelligence Consortium, research continues to show that adaptive treatment can enable dose ...

Read more

Proton Therapy Center at UAB: A Single-Vault Center. A Singular Achievement.

Centerline

Since opening its doors in March 2020, Proton International at UAB—a collaboration between the University of Alabama at Birmingham and Proton International—has been a remarkable success story.

Read more

Varian Steps in to Assist UPMC with Patient Treatments After Cyberattack on Irish Health Service

Centerline

In May of this year, the Republic of Ireland’s health service became the victim of a ransomware cyberattack. The Health Service Executive (HSE) was forced to shut down all of its IT systems following the attack, significantly disrupting services, includi...

Read more